大眾篩查市場規模,份額和趨勢分析報告:按地區(國家,州),按產品(硬件設備),按業務(醫院),按性別,按類型,按年齡,按地區,分部預測2023-2030

團體體檢市場增長及趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球大規模篩查市場預計將達到 382 億美元。從 2023 年到 2030 年，該市場預計將以 5.36% 的複合年增長率增長。市場增長歸因於疾病流行率的增加、老年人口的增加、對大規模篩查測試的投資增加等。此外，這些測試中不斷增加的技術進步和發展預計將顯著推動市場。

預計心血管疾病患病率上升將推動該領域的增長。據世界衛生組織統計，心血管疾病每年導致 1770 萬人死亡，佔全球所有死亡人數的 31.0%。高血壓及其不利的病態影響也使人們更容易患上其他心髒病，例如心力衰竭和中風。世界範圍內有多種材料原纖化篩查項目，旨在降低死亡率。早期識別高血壓和其他心血管疾病對於預測和預防與這些疾病相關的主要死亡率和發病率具有重要意義。

脊髓性肌萎縮症 (SMA) 等罕見遺傳病的患病率上升以及人口篩查支出的增加是市場主導地位的主要驅動因素。根據國家罕見病組織 (NORD) 的數據，SMA 影響了全世界大約 10,000 人中的 1 人。據 SMA Canada 稱，截至 2022 年 7 月，據信加拿大約有 700 人患有這種疾病。例如，CDC 已根據全州通用新生兒計劃向每個州發布了推薦的統一篩查小組 (RUSP)，以早期發現患有 SMA 的兒童。因此，政府正在採取此類舉措進行人口篩查，從而支持大規模篩查市場的增長。

市場參與者正在採用產品發布策略來加強他們的產品組合，並為患者提供多樣化、技術先進和創新的大規模篩查產品。一些市場參與者正在進行併購以加強其市場地位。這種戰略使公司能夠增加他們的能力，擴大他們的產品組合併提高他們的能力。例如，2022 年 8 月，Thermo Fisher Scientific 推出了 HIV-1 基因分型試劑盒，用於識別抗逆轉錄病毒療法 (ART) 抵抗的基因突變。該試劑盒僅用於研究目的。

大眾篩查市場報告亮點

由於 CTC 提供的癌症檢測的有效性和準確性，2022 年的市場細分將由國家細分市場主導

由於私人放映計劃的增加，預計在預測期內，高端市場將以最快的速度增長。

由於女性進行的測試數量增加，女性細分市場將成為 2022 年創收最高的細分市場

由於各國政府採取預防措施阻止疾病的發展，北美將在 2022 年主導大規模篩查市場。

目錄

第一章 調查方法和範圍

• 市場細分
• 調查方法
• 信息採購
  • 購買的數據庫
  • 次要信息
  • 初步調查
  • 初步調查詳情
• 信息或數據分析
  • 數據分析模型
• 市場製定和驗證
• 型號詳情
  • 商品流向分析
    • 方法一:商品流動方法
    • 方法 2:使用自下而上的方法進行國別市場估算
• 全球市場:複合年增長率計算
• 調查假設
• 二級信息列表
• 主要信息列表
• 目的
• 縮略語表

第二章執行摘要

• 市場快照
• 段快照
• 競爭格局的快照

3. 大規模篩查市場變量、趨勢和範圍

• 大眾篩查市場體系展望
  • 母公司市場展望
    • 細胞健康篩查市場展望
    • 體外診斷市場展望
• 繪製滲透率和增長前景
• 市場驅動力分析
  • 疾病流行率增加
  • 增加對大規模篩查的投資
  • 老年人口不斷增長
• 市場約束因素分析
  • 與篩查相關的高成本
  • 心理因素、知識、態度、信念
• 按因素（政治和法律、經濟、技術）的 SWOT 分析
• 波特五力分析
• 監管框架

第 4 章大眾篩查市場細分分析，按地區，區域年份從 2018 年開始（百萬美元）

• 定義和範圍
• 大眾篩查市場:區域差異分析
  • 國家
  • 狀態

5 大眾篩查市場-細分分析，副產品，2018-2030（百萬美元）

• 大眾篩查市場:產品差異分析
  • 硬件設備（器件、套件、芯片）
  • 測試/實驗室（服務）
  • 分析/解釋（個性化和解釋）

6. 大眾篩查市場-細分分析，按業務劃分，2018-2030 年（百萬美元）

• 定義和範圍
• 體檢市場:業務波動分析
  • 醫院
  • 調查
  • 診斷實驗室

7. 大眾篩查市場-細分分析，性別，2018-2030（百萬美元）

• 定義和範圍
• 大眾篩查市場:性別差異分析
  • 男人
  • 女士

8 大眾篩查市場 - 細分分析，按類型，2018-2030（百萬美元）

• 定義和範圍
• 大規模篩查市場:類型差異分析
  • 大量的
  • 優質的

9 大眾篩查市場 - 細分分析，按年齡劃分，2018-2030 年（百萬美元）

• 定義和範圍
• 大眾篩查市場:年齡變化分析
  • 15歲以下
    • 根據 15 項市場估計和預測，2018-2030 年（百萬美元）
  • 15-65歲
  • 65+

第10章區域業務分析

• 定義和範圍
• 2021 年和 2030 年區域市場份額分析
• 區域市場儀表板
• 區域市場快照
• SWOT 分析，按因素（政治和法律、經濟和技術）
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 多邊環境協定
• 2021-2030 年市場規模、預測和趨勢分析
• 北美
  • 美國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 加拿大
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
• 歐洲
  • 英國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 德國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 西班牙
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 法國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 意大利
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 丹麥
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 瑞典
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 挪威
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
• 亞太地區
  • 日本
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 中國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 印度
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 韓國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 泰國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 澳大利亞
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
• 拉丁美洲
  • 巴西
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 墨西哥
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 阿根廷
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
• 多邊環境協定
  • 南非
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 沙特阿拉伯
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 阿拉伯聯合酋長國
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景
  • 科威特
    • 主要國家動態
    • 監管框架
    • 競爭情景
    • 最近的發展
    • 投資場景

第 11 章 競爭分析

• 公司/競爭對手分類（主要創新者、市場領導者、初創企業）
• 戰略框架
• 市場參與的分類
• 主要市場進入者的最新發展和影響分析
• 公司定位分析
• 代理商名單
  • 主要客戶
  • 上市公司
  • 民營企業
• 案例分析
  • 篩查與未篩查 Cvd 患者的成本分析
  • 案例研究:大眾健康檢查
  • 案例研究:使用 Agilent Quickprobe GC/M 系統檢查原始樣本
  • 案例研究:評估 Roche Cobas 4800 HPV 測試的性能以評估用於篩查的 HPV 測試
  • 案例研究:測量糖尿病患者的葡萄糖和血紅蛋白

第十二章公司簡介

• 公司簡介
  • AGILENT TECHNOLOGIES, INC.
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • THERMO FISHER SCIENTIFIC, INC.
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • QIAGEN
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • F. HOFFMANN-LA ROCHE LTD
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • QUEST DIAGNOSTICS
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • ILLUMINA, INC
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • ARUP LABORATORIES
    • 公司簡介
    • 產品基準
    • 戰略舉措
  • NOVOGENE CO., LTD.
    • 公司簡介
    • 產品基準
    • 戰略舉措
  • LGC LIMITED
    • 公司簡介
    • 產品基準
    • 戰略舉措
  • GENE BY GENE, LTD.
    • 公司簡介
    • 產品基準

Population Screening Market Growth & Trends:

The global population screening market size is expected to reach USD 38.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.36% from 2023 to 2030. The growth of the market is attributed to the increasing prevalence of diseases, the growing geriatric population, and increasing investment in population screening tests. Moreover, the market is expected to be driven significantly by increasing technological advancements and developments in these tests.

An increase in the prevalence of cardiovascular diseases is expected to boost segment growth. According to the WHO, 17.7 million people die annually due to cardiovascular diseases, which is 31.0% of the total deaths occurring worldwide. Cardiovascular diseases are the leading cause of mortality and morbidity in the U.S. They are among the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. There are multiple screening programs available for material fibrillation globally that aim to reduce the mortality rate. Identifying early-stage hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases.

The growing prevalence of rare genetic diseases such as Spinal Muscular Atrophy (SMA) disorders and increased spending on population screening are among the major factors for the dominance of the market. According to the National Organization for Rare Disorders (NORD), SMA affects almost one in 10,000 people globally. In addition, according to SMA Canada, approximately 700 people were living with this condition in Canada as of July 2022. For instance, the CDC released the Recommended Uniform Screening Panel (RUSP) to states under its statewide universal newborn programs for the early identification of children with SMA. Thus, such initiatives are undertaken by governments to screen the population, thereby supporting the growth of the population screening market.

Players in the market adopt the strategy of product launches to strengthen their product portfolio and offer diverse, technologically advanced, & innovative population screening products to patients. Several market players engage in mergers & acquisitions to strengthen their market position. This strategy enables companies to boost their capabilities, expand product portfolios, and improve competencies. For instance, in August 2022, Thermo Fisher Scientific, Inc., launched an HIV-1 genotyping kit to identify the genetic mutations that resist Antiretroviral Therapeutics (ART). This kit was intended only for research purposes.

Population Screening Market Report Highlights:

• The nation segment held a dominant share of the market in 2022 owing to the effectiveness and precision offered by CTCs in the detection of cancer

• The premium segment is projected to grow at the fastest rate over the forecast period owing to the increasing dominance of private screening programs

• The female segment is the highest revenue-generating segment in 2022 owing to the increasing number of tests being performed by females

• North America dominated the population screening market in 2022, which is attributed to preventive measures undertaken by governments to stop the progression of diseases

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Secondary Sources
  • 1.3.3 Primary Research
  • 1.3.4 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Primary Sources
• 1.11 Objectives
  • 1.11.1 Objective 1
  • 1.11.2 Objective 2
• 1.12 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Popular Screening Market Variables, Trends & Scope

• 3.1 Population Screening Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
    • 3.1.1.1 Cellular Health Screening Market Outlook
    • 3.1.1.2 In Vitro Diagnostics Market Outlook
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Market Driver Analysis
  • 3.3.1 Increasing Prevalence Of Diseases
  • 3.3.2 Growing Investments In Population Screening
  • 3.3.3 Growing Geriatric Population
• 3.4 Market Restraint Analysis
  • 3.4.1 High Cost Associated With Screening
  • 3.4.2 Psychological Factors, Knowledge, Attitudes, And Beliefs
• 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
• 3.6 Porter's Five Forces Analysis
• 3.7 Regulatory Framework

Chapter 4 Population Screening Market - Segment Analysis, by Geography, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Population Screening Market: Geography Movement Analysis
  • 4.2.1 Nation
    • 4.2.1.1 Nation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.2.2 State
    • 4.2.2.1 State market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Population Screening Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 5.1 Population Screening Market: Product Movement Analysis
  • 5.1.1 Hardware Equipment (Instrument, Kits, Chips)
    • 5.1.1.1 Hardware Equipment (Instrument, Kits, Chips) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 5.1.2 Testing/Lab (Services)
    • 5.1.2.1 Testing/Lab (Services) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 5.1.3 Analytics/Interpretation (Personalization And Interpretation)
    • 5.1.3.1 Analytics/Interpretation (Personalisation and interpretation) market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Population Screening Market - Segment Analysis, by Business, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 Population Screening Market: Business Movement Analysis
  • 6.2.1 Hospitals
    • 6.2.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 6.2.2 Research Institutes
    • 6.2.2.1 Research Institutes Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 6.2.3 Diagnostic Labs
    • 6.2.3.1 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Population Screening Market - Segment Analysis, by Gender, 2018 - 2030 (USD Million)

• 7.1 Definition and Scope
• 7.2 Population Screening Market: Gender Movement Analysis
  • 7.2.1 Male
    • 7.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 7.2.2 Female
    • 7.2.2.1 Female market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Population Screening Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

• 8.1 Definition and Scope
• 8.2 Population Screening Market: Type Movement Analysis
  • 8.2.1 Mass
    • 8.2.1.1 Mass Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.2.2 Premium
    • 8.2.2.1 Premium market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Population Screening Market - Segment Analysis, by Age, 2018 - 2030 (USD Million)

• 9.1 Definition and Scope
• 9.2 Population Screening Market: Age Movement Analysis
  • 9.2.1 Age <15
    • 9.2.1.1 Age <15 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.2.2 15-65
    • 9.2.2.1 15-65 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.2.3 Ages 65+
    • 9.2.3.1 Ages 65+ market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Regional Business Analysis

• 10.1 Definition & Scope
• 10.2 Regional Market Share Analysis, 2021 & 2030
• 10.3 Regional Market Dashboard
• 10.4 Regional Market Snapshot
• 10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 10.5.1 North America
  • 10.5.2 Europe
  • 10.5.3 Asia Pacific
  • 10.5.4 Latin America
  • 10.5.5 MEA
• 10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
• 10.7 North America
  • 10.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD MILLION)
  • 10.7.2 U.S.
    • 10.7.2.1 U.S. Population Screening Market, 2018 - 2030 (USD Million)
    • 10.7.2.2 Key country Dynamics
    • 10.7.2.3 Regulatory Framework
    • 10.7.2.4 Competitive Scenario
    • 10.7.2.5 Recent Developments
    • 10.7.2.6 Investments Scenario
  • 10.7.3 Canada
    • 10.7.3.1 Canada Population Screening Market, 2018 - 2030 (USD Million)
    • 10.7.3.2 Key country Dynamics
    • 10.7.3.3 Regulatory Framework
    • 10.7.3.4 Competitive Scenario
    • 10.7.3.5 Recent Developments
    • 10.7.3.6 Investments Scenario
• 10.8 Europe
  • 10.8.1 Europe Population Screening Market, 2018 - 2030 (USD Million)
  • 10.8.2 UK
    • 10.8.2.1 UK Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.2.2 Key country Dynamics
    • 10.8.2.3 Regulatory Framework
    • 10.8.2.4 Competitive Scenario
    • 10.8.2.5 Recent Developments
    • 10.8.2.6 Investments Scenario
  • 10.8.3 Germany
    • 10.8.3.1 Germany Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.3.2 Key country Dynamics
    • 10.8.3.3 Regulatory Framework
    • 10.8.3.4 Competitive Scenario
    • 10.8.3.5 Recent Developments
    • 10.8.3.6 Investments Scenario
  • 10.8.4 Spain
    • 10.8.4.1 Spain Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.4.2 Key country Dynamics
    • 10.8.4.3 Regulatory Framework
    • 10.8.4.4 Competitive Scenario
    • 10.8.4.5 Recent Developments
    • 10.8.4.6 Investments Scenario
  • 10.8.5 France
    • 10.8.5.1 France Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.5.2 Key country Dynamics
    • 10.8.5.3 Regulatory Framework
    • 10.8.5.4 Competitive Scenario
    • 10.8.5.5 Recent Developments
    • 10.8.5.6 Investments Scenario
  • 10.8.6 Italy
    • 10.8.6.1 Italy Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.6.2 Key country Dynamics
    • 10.8.6.3 Regulatory Framework
    • 10.8.6.4 Competitive Scenario
    • 10.8.6.5 Recent Developments
    • 10.8.6.6 Investments Scenario
  • 10.8.7 Denmark
    • 10.8.7.1 Denmark Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.7.2 Key country Dynamics
    • 10.8.7.3 Regulatory Framework
    • 10.8.7.4 Competitive Scenario
    • 10.8.7.5 Recent Developments
    • 10.8.7.6 Investments Scenario
  • 10.8.8 Sweden
    • 10.8.8.1 Sweden Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.8.2 Key country Dynamics
    • 10.8.8.3 Regulatory Framework
    • 10.8.8.4 Competitive Scenario
    • 10.8.8.5 Recent Developments
    • 10.8.8.6 Investments Scenario
  • 10.8.9 Norway
    • 10.8.9.1 Norway Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.9.2 Key country Dynamics
    • 10.8.9.3 Regulatory Framework
    • 10.8.9.4 Competitive Scenario
    • 10.8.9.5 Recent Developments
    • 10.8.9.6 Investments Scenario
• 10.9 Asia Pacific
  • 10.9.1 Asia-Pacific Population Screening Market, 2018 - 2030 (USD Million)
  • 10.9.2 Japan
    • 10.9.2.1 Japan Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.2.2 Key Country Dynamics
    • 10.9.2.3 Regulatory Framework
    • 10.9.2.4 Competitive Scenario
    • 10.9.2.5 Recent Developments
    • 10.9.2.6 Investments Scenario
  • 10.9.3 China
    • 10.9.3.1 China Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.3.2 Key Country Dynamics
    • 10.9.3.3 Regulatory Framework
    • 10.9.3.4 Competitive Scenario
    • 10.9.3.5 Recent Developments
    • 10.9.3.6 Investments Scenario
  • 10.9.4 India
    • 10.9.4.1 India Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.4.2 Key Country Dynamics
    • 10.9.4.3 Regulatory Framework
    • 10.9.4.4 Competitive Scenario
    • 10.9.4.5 Recent Developments
    • 10.9.4.6 Investments Scenario
  • 10.9.5 South Korea
    • 10.9.5.1 South Korea Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.5.2 Key Country Dynamics
    • 10.9.5.3 Regulatory Framework
    • 10.9.5.4 Competitive Scenario
    • 10.9.5.5 Recent Developments
    • 10.9.5.6 Investments Scenario
  • 10.9.6 Thailand
    • 10.9.6.1 Thailand Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.6.2 Key Country Dynamics
    • 10.9.6.3 Regulatory Framework
    • 10.9.6.4 Competitive Scenario
    • 10.9.6.5 Recent Developments
    • 10.9.6.6 Investments Scenario
  • 10.9.7 Australia
    • 10.9.7.1 Australia Population Screening Market, 2018 - 2030 (USD Million)
    • 10.9.7.2 Key country Dynamics
    • 10.9.7.3 Regulatory Framework
    • 10.9.7.4 Competitive Scenario
    • 10.9.7.5 Recent Developments
    • 10.9.7.6 Investments Scenario
• 10.10 Latin America
  • 10.10.1 Latin America Population Screening Market, 2018 - 2030 (USD Million)
  • 10.10.2 Brazil
    • 10.10.2.1 Brazil Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.2.2 Key Country Dynamics
    • 10.10.2.3 Regulatory Framework
    • 10.10.2.4 Competitive Scenario
    • 10.10.2.5 Recent Developments
    • 10.10.2.6 Investments Scenario
  • 10.10.3 Mexico
    • 10.10.3.1 Mexico Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.3.2 Key Country Dynamics
    • 10.10.3.3 Regulatory Framework
    • 10.10.3.4 Competitive Scenario
    • 10.10.3.5 Recent Developments
    • 10.10.3.6 Investments Scenario
  • 10.10.4 Argentina
    • 10.10.4.1 Argentina Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.4.2 Key Country Dynamics
    • 10.10.4.3 Regulatory Framework
    • 10.10.4.4 Competitive Scenario
    • 10.10.4.5 Recent Developments
    • 10.10.4.6 Investments Scenario
• 10.11 MEA
  • 10.11.1 Mea Population Screening Market, 2018 - 2030 (Usd Million)
  • 10.11.2 South Africa
    • 10.11.2.1 South Africa Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.2.2 Key Country Dynamics
    • 10.11.2.3 Regulatory Framework
    • 10.11.2.4 Competitive Scenario
    • 10.11.2.5 Recent Developments
    • 10.11.2.6 Investments Scenario
  • 10.11.3 Saudi Arabia
    • 10.11.3.1 Saudi Arabia Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.3.2 Key Country Dynamics
    • 10.11.3.3 Regulatory Framework
    • 10.11.3.4 Competitive Scenario
    • 10.11.3.5 Recent Developments
    • 10.11.3.6 Investments Scenario
  • 10.11.4 UAE
    • 10.11.4.1 Uae Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.4.2 Key Country Dynamics
    • 10.11.4.3 Regulatory Framework
    • 10.11.4.4 Competitive Scenario
    • 10.11.4.5 Recent Developments
    • 10.11.4.6 Investments Scenario
  • 10.11.5 Kuwait
    • 10.11.5.1 Kuwait Population Screening Market, 2018 - 2030 (USD Million)
    • 10.11.5.2 Key country Dynamics
    • 10.11.5.3 Regulatory Framework
    • 10.11.5.4 Competitive Scenario
    • 10.11.5.5 Recent Developments
    • 10.11.5.6 Investments Scenario

Chapter 11 Competitive Analysis

• 11.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
• 11.2 Strategy Framework
• 11.3 Market Participation Categorization
• 11.4 Recent Developments & Impact Analysis, by Key Market Participants
• 11.5 Company Position Analysis
• 11.6 List of Distributors
  • 11.6.1 Key Customers
  • 11.6.2 Public Companies
  • 11.6.3 Private Companies
• 11.7 Case Studies
  • 11.7.1 Cost Analysis Of Cvd Patients With Screening Vs No Screening
  • 11.7.2 Case Study: Population Health Screening
  • 11.7.3 Case Study: Screening Of Raw Cases Samples Using The Agilent Quickprobe Gc/Ms System
  • 11.7.4 Case Study: Evaluate The Performance Of Roche Cobas 4800 Hpv Test For Evaluating Hpv Tests For Screening
  • 11.7.5 Case Study: Measurement Of Glucose And Hemoglobin In Diabetes

Chapter 12 COMPANY PROFILES

• 12.1 Company Profiles
  • 12.1.1 AGILENT TECHNOLOGIES, INC.
    • 12.1.1.1 Company Overview
    • 12.1.1.2 Financial Performance
    • 12.1.1.3 Product Benchmarking
    • 12.1.1.4 Strategic Initiatives
  • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
    • 12.1.2.1 Company Overview
    • 12.1.2.2 Financial performance
    • 12.1.2.3 Product Benchmarking
    • 12.1.2.4 Strategic Initiatives
  • 12.1.3 QIAGEN
    • 12.1.3.1 Company Overview
    • 12.1.3.2 Financial performance
    • 12.1.3.3 Product Benchmarking
    • 12.1.3.4 Strategic Initiatives
  • 12.1.4 F. HOFFMANN-LA ROCHE LTD
    • 12.1.4.1 Company Overview
    • 12.1.4.2 Financial performance
    • 12.1.4.3 Product Benchmarking
    • 12.1.4.4 Strategic Initiatives
  • 12.1.5 QUEST DIAGNOSTICS
    • 12.1.5.1 Company Overview
    • 12.1.5.2 Financial performance
    • 12.1.5.3 Product Benchmarking
    • 12.1.5.4 Strategic Initiatives
  • 12.1.6 ILLUMINA, INC
    • 12.1.6.1 Company Overview
    • 12.1.6.2 Financial performance
    • 12.1.6.3 Product Benchmarking
    • 12.1.6.4 Strategic Initiatives
  • 12.1.7 ARUP LABORATORIES
    • 12.1.7.1 Company Overview
    • 12.1.7.2 Product Benchmarking
    • 12.1.7.3 Strategic Initiatives
  • 12.1.8 NOVOGENE CO., LTD.
    • 12.1.8.1 Company Overview
    • 12.1.8.2 Product Benchmarking
    • 12.1.8.3 Strategic Initiatives
  • 12.1.9 LGC LIMITED
    • 12.1.9.1 Company Overview
    • 12.1.9.2 Product Benchmarking
    • 12.1.9.3 Strategic Initiatives
  • 12.1.10 GENE BY GENE, LTD.
    • 12.1.10.1 Company Overview
    • 12.1.10.2 Product Benchmarking

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Regulatory Framework
• Table 4 Global Population Screening Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 6 Global Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 7 Global Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 8 Global Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 9 Global Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 10 Global Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 11 North America Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 12 North America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 13 North America Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 14 North America Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 15 North America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 16 North America Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 17 North America Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 18 U.S. Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 19 U.S. Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 20 U.S. Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 21 U.S. Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 22 U.S. Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 23 U.S. Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 24 Canada Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 25 Canada Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 26 Canada Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 27 Canada Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 28 Canada Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 29 Canada Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 30 Europe Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 31 Europe Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 32 Europe Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 33 Europe Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 34 Europe Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 35 Europe Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 36 Europe Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 37 UK Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 38 UK Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 39 UK Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 40 UK Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 41 UK Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 42 UK Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 43 Germany Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 44 Germany Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 45 Germany Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 46 Germany Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 47 Germany Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 48 Germany Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 49 France Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 50 France Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 51 France Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 52 France Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 53 France Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 54 France Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 55 Spain Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 56 Spain Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 57 Spain Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 58 Spain Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 59 Spain Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 60 Spain Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 61 Italy Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 62 Italy Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 63 Italy Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 64 Italy Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 65 Italy Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 66 Italy Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 67 Denmark Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 68 Denmark Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 69 Denmark Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 70 Denmark Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 71 Denmark Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 72 Denmark Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 73 Sweden Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 74 Sweden Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 75 Sweden Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 76 Sweden Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 77 Sweden Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 78 Sweden Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 79 Norway Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 80 Norway Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 81 Norway Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 82 Norway Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 83 Norway Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 84 Norway Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 85 Asia Pacific Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 86 Asia Pacific Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 87 Asia Pacific Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 88 Asia Pacific Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 89 Asia Pacific Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 90 Asia Pacific Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 91 Asia Pacific Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 92 Japan Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 93 Japan Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 94 Japan Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 95 Japan Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 96 Japan Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 97 Japan Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 98 China Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 99 China Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 100 China Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 101 China Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 102 China Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 103 China Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 104 Australia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 105 Australia Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 106 Australia Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 107 Australia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 108 Australia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 109 Australia Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 110 Thailand Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 111 Thailand Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 112 Thailand Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 113 Thailand Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 114 Thailand Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 115 Thailand Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 116 India Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 117 India Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 118 India Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 119 India Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 120 India Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 121 India Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 122 South Korea Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 123 South Korea Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 124 South Korea Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 125 South Korea Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 126 South Korea Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 127 South Korea Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 128 Latin America Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 129 Latin America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 130 Latin America Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 131 Latin America Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 132 Latin America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 133 Latin America Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 134 Latin America Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 135 Mexico Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 136 Mexico Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 137 Mexico Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 138 Mexico Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 139 Mexico Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 140 Mexico Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 141 Brazil Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 142 Brazil Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 143 Brazil Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 144 Brazil Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 145 Brazil Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 146 Brazil Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 147 Argentina Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 148 Argentina Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 149 Argentina Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 150 Argentina Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 151 Argentina Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 152 Argentina Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 153 MEA Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 154 MEA Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 155 MEA Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 156 MEA Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 157 MEA Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 158 MEA Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 159 MEA Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 160 South Africa Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 161 South Africa Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 162 South Africa Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 163 South Africa Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 164 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 165 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 166 South Africa Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 167 Saudi Arabia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 168 Saudi Arabia Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 169 Saudi Arabia Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 170 Saudi Arabia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 171 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 172 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 173 Saudi Arabia Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 174 UAE Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 175 UAE Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 176 UAE Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 177 UAE Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 178 UAE Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 179 UAE Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 180 Kuwait Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 181 Kuwait Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 182 Kuwait Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 183 Kuwait Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 184 Kuwait Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 185 Kuwait Population Screening Market, By Age, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Population screening market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Commodity flow approach
• Fig. 10 Market snapshot (2022) (USD Million)
• Fig. 11 Segment Snapshot (2022) (USD Million)
• Fig. 12 Segment Snapshot (2022) (USD Million)
• Fig. 13 Segment Snapshot (2022) (USD Million)

Fig. 14 Market Outlook (2022) (USD Million)

• Fig. 15 Penetration & growth prospect mapping
• Fig. 16 Population screening market driver impact
• Fig. 17 Global cancer cases projection, 2020-2030 (Number of newly registered cases)
• Fig. 18 Distinguishing screening from early diagnosis of cancer according to symptom onset
• Fig. 19 Elderly population total, % of the global population
• Fig. 20 Population screening market restraint impact
• Fig. 21 PESTEL analysis
• Fig. 22 Porter's Five Forces analysis
• Fig. 23 Population screening geography outlook: Key takeaways
• Fig. 24 Population screening market: Geography movement analysis
• Fig. 25 Nation market 2018 - 2030 (USD Million)
• Fig. 26 State market, 2018 - 2030 (USD Million)
• Fig. 27 Population screening product analysis outlook: Key takeaways
• Fig. 28 Population screening market: Product movement analysis
• Fig. 29 Hardware and Equipment market, 2018 - 2030 (USD Million)
• Fig. 30 Testing/lab (services) market, 2018 - 2030 (USD Million)
• Fig. 31 Analytics/interpretation market, 2018 - 2030 (USD Million)
• Fig. 32 Population screening business outlook: Key takeaways
• Fig. 33 Population screening market: business analysis
• Fig. 34 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 35 Research institute market, 2018 - 2030 (USD Million)
• Fig. 36 Diagnostic labs market, 2018 - 2030 (USD Million)
• Fig. 37 Population screening gender outlook: Key takeaways
• Fig. 38 Population screening market: Gender analysis
• Fig. 39 Male market, 2018 - 2030 (USD Million)
• Fig. 40 Current screening statistics CDC (2022)
• Fig. 41 Female market, 2018 - 2030 (USD Million)
• Fig. 42 Population screening type outlook: Key takeaways
• Fig. 43 Population screening market: Type analysis
• Fig. 44 Mass market, 2018 - 2030 (USD Million)
• Fig. 45 Premium market, 2018 - 2030 (USD Million)
• Fig. 46 Population screening age outlook: Key takeaways
• Fig. 47 Population screening market: Age analysis
• Fig. 48 Ages 15 market, 2018 - 2030 (USD Million)
• Fig. 49 15-65 years market, 2018 - 2030 (USD Million)
• Fig. 50 Ages 65+ years market, 2018 - 2030 (USD Million)
• Fig. 51 Regional snapshot, 2021 & 2030
• Fig. 52 Regional marketplace: Key takeaways
• Fig. 53 Crude & effective coverage for cervical cancer screening across women aged 25 - 64
• Fig. 54 Global population screening market, 2018 - 2030 (USD Million)
• Fig. 55 North America population screening market, 2018 - 2030 (USD Million)
• Fig. 56 Europe population screening market, 2018 - 2030 (USD Million)
• Fig. 57 Asia Pacific population screening market, 2018 - 2030 (USD Million)
• Fig. 58 Latin America population screening market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East and Africa population screening market, 2018 - 2030 (USD Million)
• Fig. 60 GCC population screening market, 2018 - 2030 (USD Million)
• Fig. 61 Rest of GCC population screening market, 2018 - 2030 (USD Million)
• Fig. 62 UAE population screening market, 2018 - 2030 (USD Million)
• Fig. 63 Australia population screening market, 2018 - 2030 (USD Million)
• Fig. 64 Percentage of screening for chronic diseases in 2017 and 2020
• Fig. 65 Singapore population screening market, 2018 - 2030 (USD Million)
• Fig. 66 UK population screening market, 2018 - 2030 (USD Million)
• Fig. 67 Thailand population screening market, 2018 - 2030 (USD Million)
• Fig. 68 ASEAN countries population screening market, 2018 - 2030 (USD Million)
• Fig. 69 Recent company/competition categorization